Apelin: A putative novel predictive biomarker for bevacizumab response in colorectal cancer

Linda Zuurbier, Arman Rahman, Martijn Cordes, Jennifer Scheick, Tse J. Wong, François Rustenburg, Jesu Christopher Joseph, Peter Dynoodt, Rory Casey, Paul Drillenburg, Michael F. Gerhards, Ana Barat, Rut Klinger, Bozena Fender, Darran P. O'Connor, Johannes Betge, Matthias P Ebert, Timo Gaiser, Jochen H M Prehn, Arjan W. GriffioenNicole C.T. van Grieken, Bauke Ylstra, Annette T Byrne, Laurens G. van der Flier, William M. Gallagher, William M. Gallagher, Ruben Postel

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)42949-42961
Number of pages13
JournalOncotarget
Volume8
Issue number26
DOIs
Publication statusPublished - 1 Jan 2017

Cite this

Zuurbier, L., Rahman, A., Cordes, M., Scheick, J., Wong, T. J., Rustenburg, F., ... Postel, R. (2017). Apelin: A putative novel predictive biomarker for bevacizumab response in colorectal cancer. Oncotarget, 8(26), 42949-42961. https://doi.org/10.18632/oncotarget.17306